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Abstract
It is known that aminoglycoside antibiotics can damage the vestibular and auditory sensory epithelia, and the loop diuretics
can enhance the ototoxic effect of aminoglycosides. Previous studies on the synergistic effect of these two types of drugs have
used mice, guinea pigs and cats, but not rats. The aim of this study was to determine this synergistic effects in rat cochleae.
Rats received intravenous injections of different doses of furosemide and/or intramuscular injections of kanamycin sulfate. Au-
ditory brainstem response (ABR), scanning electron microscopy (SEM) and immunocytochemistry were used to determine the
effects of drug administration. In the group receiving combined administration of furosemide and kanamycin, the ABR thresh-
old showed significant elevation 3 days after drug administration, greater than single drug administration. The hair cells
showed various degrees of injury from the apical turn to the basal turn of the cochlea and from the outer hair cells to the inner
hair cells. Neuron fibers of the hair cells showed significant loss 7 days after the drug administration, but the number of spiral
ganglia did not decrease and supporting cells showed no signs of injury. Our study suggest that combined administration of fu-
rosemide and kanamycin has an synergistic ototoxic effect, and can result in hair cell loss and hearing loss in rats.
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Introduction
The animal model of deafness is an important tool
in studying the pathogenesis of deafness and hearing
regeneration. It can be created through noise exposure,
ototoxic drug administration and gene manipula-
tion. Drug administration is more frequently used than
the other two due to its rather complete elimination of
auditory hair cells. To date, numerous methods have
been developed using ototoxic drugs to induce deaf-
ness, including local application of carboplatin and cis-
platin, neomycin infiltration through the round window
membrane [1,2], and intramuscular injection of kanamy-
cin, gentamicin and amikacin [3]. Nevertheless, these
methods may bring uncontrollable side effects other
than deafness, e.g., infection and mechanical damage
of the inner ear from local administration of ototoxic
drugs; and severe kidney dysfunction with high mortali-
ty from systemic administration of aminoglycosides.
Therefore, safer and more effective drug administration
methods need to be explored. Fortunately, combined ap-
plication of aminoglycosides and loop diuretics, such
as kanamycin and furosemide, has been demonstrated
to be able to cause hair cell injury in a faster and safer
manner [4-9]. This inspired us to explore a novel method
to construct deafness models. In this study, we aimed
to testifying the synergistic effect of kanamycin and fu-
rosemide in rat cochleae and establishing a preliminary
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criterion in drug dosages for deafness induction. The
reason of choosing rats was that they are more advanta-
geous than other rodent species for deafness model
construction. First, rats costs lower in breeding than
guinea pigs. Second, rats have a larger body than
mice, more suitable for cochlear surgeries. The audito-
ry brainstem response (ABR) was measured to deter-
mine the hearing threshold after drug application. Im-
munocytochemistry and confocal microscopy were per-
formed to evaluate the inner ear morphology. To our
knowledge, this is the first report of establishing rat
deafness model through combinational application
of aminoglycosides and loop diuretics.
Materials and Methods
Drug Administration
Ninety healthy 4-week-old SD rats (100-110 g) were
randomly assigned into 6 groups, with 15 animals in
each group (Table 1). The animals were anesthetized
with intraperitoneal injection of 10 % chloral hydrate
(0.45 ml/100 g). The left jugular vein was exposed and
injected with furosemide, whereas kanamycin was in-
jected intramuscularly in the thigh as described previ-
ously [4]. Group A was the control without any treat-
ments. Groups B and C were injected with either furo-
semide or kanamycin alone in the doses of 200 mg/kg
or 1000 mg/kg, respectively. Groups C, D, E and F re-
ceived both drugs in different dosage combinations. All
the animals exhibited normal behavior and were on
normal diet after the drug administration, and there
were no signs of abnormal vestibular function. Care
and use of animals were approved by the Institutional
Animal Care and Use Committee of Chinese PLA Gen-
eral Hospital.
ABR Measurements
Details of ABR measurements were provided else-
where [8]. Briefly, the animals were anaesthetized with
xylazine and ketamine. The recording electrodes were
inserted at the vertex and pinna. ABRs were evoked
with clicks and/or 5 ms tone pips (0.5 ms rise/fall, at
30/sec) at frequencies of 4, 8, 16, and 32 kHz. The sig-
nal was amplified, filtered, and averaged using the In-
telligent Hearing System (USA). The sound level was
raised in 20- and/or 5-dB steps. At each level, 1024 re-
sponses were averaged. Both ears were measured.
Immunocytochemistry and Scanning Electron Mi-
croscopy
The cochleae were perfused with 4.0 % formalde-
hyde and were treated with 0.2 % Triton X-100/PBS.
Goat serum (10 %) was used to block nonspecific bind-
ing. The tissue was then incubated with 200 kD Neuro-
filament Heavy antibody (Abcam, diluted 1:200). The
samples were washed with PBS, followed by incuba-
tion with the secondary antibodies. To stain nuclei, the
DNA-specific label propidium iodide (PI) was used as
described previously [10]. The samples were mounted on
the glass slides with antifade solution (Prolong Anti-
fade Kit, Molecular Probes) and examined using confo-
cal scanning system (LSM 510 META, USA) with
three lasers mounted on a Zeiss AxioPlan 2IE MOT
motorized upright microscope.
For SEM, the cochleae were fixed with 2.5 % glutar-
aldehyde in the 0.1 M sodium cacodylate buffer (pH
7.4) containing 2 mM CaCl2, then was washed in PBS
and post-fixed for 15 minutes with 1 % OSO4 in the
same buffer. The tissues were dehydrated in an ethanol
series, critical point dried from CO2 and sputter-coated
with gold then examined using a Hitachi S-3700N
scanning electron microscope.
Statistical Analysis
All the data were analyzed using the statistical soft-
ware STATA7.0 (STATA Corp, L.P., College Station,
TX, USA). The student’s t test was applied with p
value 0.05 being significant. The data were presented
as mean ±standard deviation (SD).
Results
ABR Results
We performed ABR measurements at three time
points after the drug administration (3 days, 1 week
and 2 months, respectively). The purpose of doing so
was to test whether the combined administration of fu-
rosemide and kanamycin would be able to induce sta-
ble hearing loss over a long-term period. Fig. 1 shows
the average ABR thresholds of each group measured at
four testing frequencies (4, 8, 16 and 32 kHz). Com-
pared with the control (group A) at any time point, the
ABR thresholds of the groups receiving kanamycin or
furosemide alone (Groups B and C) did not show sig-
nificant changes at all four frequencies tested (Fig. 1;
p> 0.05). In the groups receiving both drugs (Groups
D, E and F), however, the ABR thresholds were elevat-
ed significantly at all tested frequencies (p <0.01). In
Groups D and E, we applied the same dose of furose-
mide (100 mg/kg), but used different doses of kanamy-
cin (500 mg/kg for Group D and 1000 mg/kg for
Group E). We noticed that the higher dose of kanamy-
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cin caused more hearing impairment, manifested by a
higher elevation of ABR thresholds in Group E than
D. By contrast, Group F received twice the dose of fu-
rosemide (200 mg/kg), but a very low dose of kanamy-
cin (100 mg/kg). Surprisingly, the ABR thresholds ele-
vation exceeded maximum stimulus intensity (110 dB
SPL) of the test system.
SEM of the Basilar Membrane
Scanning electron microscopy (SEM) was used to
examine the basilar membrane (BM) after the drug ad-
ministration to evaluated ototoxic effects of furose-
mide and kanamycin on the auditory hair cells. In the
groups treated with furosemide or kanamycin alone
(Group B or C), the stereocilia of inner hair cells
(IHCs) and outer hair cells (OHCs) were clearly visi-
ble on the cuticular plate in normal shape and organi-
zation (Fig. 3B and C) as seen in the control (Fig.
3A). In Group D, however, the stereocilia of OHCs
were completely depleted in the basal turn while re-
maining intact in the apical and middle turns (Fig.
3D). The stereocilia of IHCs remained intact in the en-
tire BM. Similar findings were observed in Group E,
where the stereocilia of OHCs were completely miss-
ing in the BM, while the stereocilia of IHCs remained
intact in the apical turn and sporadically visible in the
middle turn, but were completely missing in the basal
turn. Different from these findings, complete depletion
of the stereocilia of both IHCs and OHCs were ob-
served throughout the entire BM in Group F. Notable
scarring of the BM was also observed.
Immunofluorescence staining
Neurofilament antibody staining and PI nuclear
staining of the whole cochlear preparation showed that
in group F, the number of the cochlear nerve fibers was
significantly reduced 7 days after combined administra-
tion of furosemide and kanamycin compared with the
control group. , Damage to the nerve fibers was gradual-
ly aggravated from the apical turn to the basal turn of
the cochlea. In the normal control group, the morpholo-
gy of the nuclei in the inner and outer hair cells was nor-
mal and the nuclear arrangement was regular. However,
in the drug administration groupF, the nuclei in the out-
er hair cells disappeared. Although the nuclei of the in-
ner hair cells were still present, the arcutecture of the
organ of Corti was disrupted (Figure 3).
Figure 1: ABR thresholds measured from six groups . A: ABR thresholds (means SD, n=30) were measured at 3 days after injection.. B:
ABR thresholds (means SD, n=30) were measured at 7days after injection.. C: ABR thresholds (means SD, n=30) were measured at
2months after injection. Tone pips with frequencies of 4, 8, 16, and 32 kHz were used to evoke ABRs.
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Discussion
Currently, it is thought that loop diuretics, such as
furosemide and ethacrynic acid, mainly cause edema
and cystic degeneration of the cochlear stria vascularis,
decrease in the magnitude of the cochlear action poten-
tial, inhibition of K +-Na +-ATP enzyme, and edema of
the outer hair cells of the organ of Corti [11,12]. The pri-
mary ototoxicity of aminoglycoside antibiotics, such as
kanamycin, affects cochlear hair cells, which results in
irreversible hearing loss [13]. In animal experiments, a
single injection of a conventional dose of loop diuret-
ics, such as furosemide, may cause reversible hearing
loss from transient disorders of the microcirculation of
the cochlear stria vascularis, but a single injection of a
conventional dose of aminoglycoside antibiotics, such
as kanamycin, often does not cause inner ear dysfunc-
tion or pathologic changes. Only after multiple injec-
tions, massive necrosis of hair cells may occur because
of the accumulation of high concentrations of kanamy-
cin in the perilymph fluid and delayed excretion [14]. In
this study, we showed that a single injection of kana-
mycin or furosemide did not cause any elevation in
ABR threshold or hair cell loss in rats. We speculated
that the reason why we did not see threshold change
may be the time points of observation after drug ad-
ministration. Because the effects of loop diuretics on
the cochlear stria vascularis are temporary, hearing
may have restored to normal in rats on the third day af-
ter drug administration. Other studies have shown that
administration of low-dose antibiotics do not cause sig-
nificant changes in cochlear sensory epithelium [15].
Previous studies have demonstrated that loop diuret-
ics and aminoglycosides may mutually reinforce ototox-
icity [16]. Yamane et al. [17] reported that furosemide
could promote the entrance of kanamycin into the in-
ner ear lymphatic space, and suggested that this was re-
lated to the effects of furosemide, enhancing the oto-
toxicity of kanamycin. Our study also showed that fu-
rosemide and kanamycin had a synergistic ototoxicity
effect. The synergistic effects of kanamycin and furose-
mide may be produced because furosemide damages
the blood - labyrinth barrier, causing a change in per-
meability, which results in easier entrance of kanamy-
cin into the inner ear. Furosemide may also damage
the excretory function of the cochlear stria vascularis,
causing slower excretion and slow accumulation of ka-
namycin in the inner ear. When furosemide was admin-
istered at a low dose (100 mg/kg), elevation of the
ABR threshold was positively related to the dose of ka-
namycin within a certain range. The combined injec-
tion of kanamycin at a low dosage (500 mg/kg) caused
a slight increase in the ABR threshold. Injection of
KM at a high dose (1000 mg/kg) caused a significant
increase in the ABR threshold. When a high dose of fu-
rosemide was given (200 mg/kg), a very small dose of
kanamycin (100 mg/kg) was required to cause ABR
thresholds > 110 dB SPL at all frequencies. The SEM
results are consistent with the ABR thresholds. When
low dose of furosemide (100 mg/kg) was given, the
loss of cochlear hair cells was positively correlated
with the dose of kanamycin within a certain range.
When high dose furosemide was given (200 mg/kg), a
very small dose of kanamycin (100 mg/kg) was suffi-
cient to cause loss of all inner and outer hair cells in
the entire cochlea. We speculate that the mechanism
for this phenomenon may be that the damage by
Figure 3. Immunofluorescence staining of the whole cochlear basi-
lar membrane preparation in group F and in the normal control
group 7 days after drug administration. A, is the basilar membrane
preparation of the basal, in normal rats.B is the basilar membrane
preparation of the basal turns of the cochlea in the rats of group F
7 days after drug administration.
Figure 2. Scanning electron microscopy of cochlear toxicity of in-
jection of furosemide and / or kanamycin sulfate in rats.A1, A2,
A3, B1, B2, B3, C1, C2, and C3 were the basal , middle, and api-
cal turns of the rat cochlea in Groups A, B, and C, respectively,
and one row of inner hair cells and three rows of outer hair cells
could be seen. D1, D2, and D3 were the basal, middle, and apical
turns of the rat cochlea in group D. In the apical and middle turns,
one row of inner hair cells and three rows of outer hair cells could
be seen. The inner hair cells were intact in the basal turn, and the
outer hair cells were completely missing. E1, E2, and E3 were the
basal, middle, and apical turns of the rat cochlea in group E. In the
apical turn, the inner hair cells were intact, and the outer hair cells
were completely missing. In the middle turn, the inner hair cells
were missing extensively, and the outer hair cells were missing
completely. In the basal turn, inner and outer hair cells were all
missing. F1, F2, and F3 were the basal , middle, and apical turns
of the rat cochlea in group F and the inner and outer hair cells in
the whole cochlea were missing. OHC: outer hair cells, IHC: inner
hair cells. Scale: A1, A2, B1, B2, C1, C2, C3, D1, D2: 12 μm; A3,
D3: 6μm; B3, E1, E2, E3: 10 μm; F1, F2, F3: 15 μm.
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low-dose furosemide (100 mg/kg) to the cochlear stria
vascularis was mild, the blood labyrinth barrier was
opened partially temporarily, and kanamycin entered in-
to the lymphatic space slowly. Therefore, injection of
large-dose kanamycin (1000 mg/kg) can result in a con-
centration that may cause severe injury to cochlear hair
cells. However, when a large dose of furosemide (200
mg/kg) was administered, furosemide caused greater
damage to the cochlear stria vascularis, the blood laby-
rinth barrier was jeopardized for a longer time, and ka-
namycin entered the lymphatic space more rapidly.
Therefore, injection of low-dose kanamycin (100 mg/
kg) resulted in rapid accumulation of kanamycin in the
inner ear. Russell et al. [6] concluded that the variable ef-
ficacy in different animals may be attributed to differ-
ent clearance rates of kanamycin and EA in animals,
and that the toxic effects of combination therapy pri-
marily depends on the dose of EA. Our study also
showed that when the dose of EA was low, even an in-
creased dose of kanamycin could only achieve 53.3%
hair cell loss. When the dose of EA was high,
low-dose kanamycin caused complete hair cell loss.
Deafness caused by combined furosemide and kana-
mycin in rats was bilaterally symmetric and hearing
loss occurred 3 days after drug administration. Histo-
logical studies on the cochlea of rats with deafness
have found that cochlear hair cell damage always grad-
ually expands from the cochlear basal turn to the api-
cal turn, and the damage to the outer hair cells always
precedes that of inner hair cells. The mechanism of fu-
rosemide- and kanamycin-induced hair cell injury may
be that the outer hair cells have greater capability to
engulf kanamycin, and that this capability is greater in
hair cells at the basal turn than hair cells at the apical
turn. We speculate that the reason why hair cells at dif-
ferent places have different drug uptake capacities is re-
lated to the distribution of drug transporters on the cell
membrane [18]. Basal turn hair cells also have more ste-
reocilia and transduction channels. Studies have shown
that after intramuscular injection of kanamycin, degen-
eration of supporting cells occurr significantly later
than hair cells and that degeneration of the spiral gan-
glion and nerve fibers takes place even later. There-
fore, it is thought that damage to the inner ear sensory
cells is the root cause of kanamycin-induced hearing
impairment [19]. Our results on the injury of the inner
ear sensory cells are consistent with previous studies.
However, we found that combined use of furosemide
and kanamycin not only caused damage to the inner
ear sensory epithelium, but also injury to auditory
nerve fibers. Nourski et al. showed that the effects of
EA and kanamycin targeted hair cell injury without
causing significant inhibition of response of the audito-
ry nerve. The reason for this difference may be the dif-
ferent time points of observation. The time points of
observation were within 10 hours after drug administra-
tion in the Nourski study, compared to 1 week after
drug administration in our observation. It is possible
that the auditory nerve fibers are not yet damaged with-
in 10 hours after drug administration, as the damage
may occur slowly. Furosemide is a loop diuretic, and
studies on ototoxicity [20] have shown that furosemide
can cause pathologic changes of border cells in the
stria vascularis, and the degree of edema of border
cells is the main indicator of ototoxicity caused by a
loop diuretic. The stria vascularis plays an important
role in maintaining inner ear micro-environment, which
is necessary for the normal activities of hair cells. The
stability of this microenvironment is critical for the
functioning and survival of hair cells.
In summary, we have established a rat model of
deafness through single administration of furosemide
or kanamycin or combined administration or the two.
We have found that only combined use of kanamycin
and furosemide result in severe hearing impairment,
with more severe injury in cochlear outer hair cells
than in inner hair cells. However, the majority of sup-
porting cells would remain undamaged. Spiral ganglion
damage may not be apparent within a short time peri-
od after drug administration, although damage to the
auditory nerve fibers has appeared. No hair cell repair
was observed in this study. When the dose of furose-
mide is high, even low doses of kanamycin can cause
serious damage to the cochlea. Single, one-time injec-
tion of furosemide or kanamycin results in little to no
cochlear damage.
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